Skip to main content
Equibles

HSG Holding Ltd

Position in LYEL — Lyell Immunopharma, Inc.

CIK 1470766 NA, K3
Back to LYEL Full portfolio

Position in LYEL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,139,800
+$2,066,696 QoQ
Shares Held
152,299
0.0% QoQ
Ownership
0.621%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#15
of 87 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LYEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HSG Holding Ltd holds $70,756,776 across 6 Biotechnology names. LYEL ranks #5 (3.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GYRE
Gyre Therapeutics, Inc.
 3,750,299 $24,714,470
2 AVBP
ArriVent BioPharma, Inc.
 663,308 $23,043,319
3 GPCR
Structure Therapeutics Inc.
 266,062 $14,279,547
4 ADAG
Adagene Inc.
 1,343,364 $5,642,128
5 LYEL
Lyell Immunopharma, Inc.
This page 		152,299 $2,139,800
6 BRNS
Barinthus Biotherapeutics plc.
 1,420,473 $937,512

All Filings in LYEL

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,139,800 152,299
2026-03-31 $73,104 152,299
2025-12-31 $4,687,763 152,299
2025-09-30 $73,104 152,299
2025-06-30 $1,346,323 152,299
2025-03-31 $1,638,746 3,045,997
2024-12-31 $1,949,438 3,045,997
2024-09-30 $4,203,475 3,045,997
2024-06-30 $4,416,695 3,045,997
2024-03-31 $6,792,573 3,045,997
2023-12-31 $5,909,234 3,045,997
2023-09-30 $4,477,615 3,045,997
2023-06-30 $9,686,270 3,045,997
2023-03-31 $7,188,552 3,045,997
2022-12-31 $10,569,609 3,045,997
2022-09-30 $22,327,158 3,045,997
2022-06-30 $19,859,900 3,045,997
2022-03-31 $15,382,283 3,045,997
2021-12-31 $23,576,016 3,045,997
2021-09-30 $45,080,755 3,045,997
2021-06-30 $39,573,599 2,436,798